Your newest ally in Alzheimer's research!
Bio-Techne has teamed up with ALZpath to bring you our latest innovation: a powerful new assay for detecting pTau 217 in cerebrospinal fluid (CSF), plasma, and serum.
Leveraging the highly characterized ALZpath pTau 217 antibody on the Ella™ Platform, this assay delivers precise, reliable results in just 90 minutes.
With minimal hands-on time and only small sample volumes required, it’s designed to integrate seamlessly into your neuroscience research workflow—giving you faster, more consistent results.
Book a demo: https://lifescience.invitro.com.au/brands/proteinsimple/contact-us
